Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group.

Authors:
Mohammad Y Zaidi
Mohammad Y Zaidi
Emory University School of Medicine
Atlanta | United States
Mary Dillhoff
Mary Dillhoff
The Ohio State University Wexner Medical Center
Columbus | United States
George A Poultsides
George A Poultsides
Stanford University School of Medicine
Zaheer S Kanji
Zaheer S Kanji
Mount Sinai Hospital
Canada
Flavio G Rocha
Flavio G Rocha
Harvard Medical School
United States

Ann Surg Oncol 2019 Apr 19. Epub 2019 Apr 19.

Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, GA, USA.

Background: Preoperative factors that reliably predict lymph node (LN) metastases in pancreatic neuroendocrine tumors (PanNETs) are unclear. The number of LNs needed to accurately stage PanNETs has not been defined.

Methods: Patients who underwent curative-intent resection of non-functional PanNETs at eight institutions from 2000 to 2016 were analyzed. Preoperative factors associated with LN metastases were identified. A procedure-specific target for LN retrieval to accurately stage patients was determined.

Results: Of 695 patients who underwent resection, 33% of tumors were proximal (head/uncinate) and 67% were distal (neck/body/tail). Twenty-six percent of patients (n = 158) had LN-positive disease, which was associated with a worse 5-year recurrence-free survival (RFS; 60% vs. 86%; p < 0.001). The increasing number of positive LNs was not associated with worse RFS. Preoperative factors associated with positive LNs included tumor size ≥ 2 cm (odds ratio [OR] 6.6; p < 0.001), proximal location (OR 2.5; p < 0.001), moderate versus well-differentiation (OR 2.1; p = 0.006), and Ki-67 ≥ 3% (OR 3.1; p < 0.001). LN metastases were also present in tumors without these risk factors: < 2 cm (9%), distal location (19%), well-differentiated (23%), and Ki-67 < 3% (16%). Median LN retrieval was 13 for pancreatoduodenectomy (PD), but only 9 for distal pancreatectomy (DP). Given that PD routinely includes a complete regional lymphadenectomy, a minimum number of LNs to accurately stage patients was not identified. However, for DP, removal of less than seven LNs failed to discriminate 5-year RFS between LN-positive and LN-negative patients (less than seven LNs: 72% vs. 83%, p = 0.198; seven or more LNs: 67% vs. 86%; p = 0.002).

Conclusions: Tumor size ≥ 2 cm, proximal location, moderate differentiation, and Ki-67 ≥ 3% are preoperative factors that predict LN positivity in resected non-functional PanNETs. Given the 9-23% incidence of LN metastases in patients without such risk factors, routine regional lymphadenectomy should be considered. PD inherently includes sufficient LN retrieval, while DP should aim to remove seven or more LNs for accurate staging.

Download full-text PDF

Source
http://link.springer.com/10.1245/s10434-019-07367-y
Publisher Site
http://dx.doi.org/10.1245/s10434-019-07367-yDOI Listing
April 2019
7 Reads

Publication Analysis

Top Keywords

neuroendocrine tumors
8
695 patients
8
patients underwent
8
pancreatic neuroendocrine
8
accurately stage
8
preoperative factors
8
patients
5
associated metastases
4
factors associated
4
patients determinedresults
4
metastases identified
4
procedure-specific target
4
target retrieval
4
stage patients
4
retrieval accurately
4
identified procedure-specific
4
2000 2016
4
underwent curative-intent
4
definedmethods patients
4
pannets definedmethods
4

References

(Supplied by CrossRef)
Article in Arch Surg.
AB Haynes et al.
Arch Surg. 2011
Article in Ann Surg.
JR Strosberg et al.
Ann Surg. 2012
Article in Surgery.
J Cherenfant et al.
Surgery. 2013
Article in J Surg Oncol.
LM Postlewait et al.
J Surg Oncol. 2016
Article in Ann Surg.
KY Bilimoria et al.
Ann Surg. 2008
Article in Gastroenterology.
DC Metz et al.
Gastroenterology. 2008
Article in Clin Cancer Res.
S Ekeblad et al.
Clin Cancer Res. 2008
Article in Medicine (Baltimore).
RD Dolan et al.
Medicine (Baltimore). 2018
Article in Eur J Surg Oncol.
J Reha et al.
Eur J Surg Oncol. 2018
Article in Eur J Surg Oncol.
J Lu et al.
Eur J Surg Oncol. 2017
Article in Am J Clin Oncol.
Alatengbaolide et al.
Am J Clin Oncol. 2013

Similar Publications